(Q37789511)

23 August 2017

title

High-dose daptomycin in documented Staphylococcus aureus infections (English)

1 reference

23 August 2017

main subject

Staphylococcus aureus

1 reference

1

Matteo Bassetti

1 reference

23 August 2017

6

Claudio Viscoli

1 reference

23 August 2017

4

Filippo Ansaldi

1 reference

23 August 2017

Daniela de Florentiis

5

object named as

Daniela de Florentiis

1 reference

23 August 2017

Elena Nicco

2

1 reference

23 August 2017

Francesca Ginocchio

3

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846832

14 July 2024

publication date

16 September 2010

1 reference

full work available at URL

23 August 2017

https://hal.archives-ouvertes.fr/hal-00629956/file/PEER_stage2_10.1016%252Fj.ijantimicag.2010.07.011.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846832

https://api.elsevier.com/content/article/PII:S0924857910003390?httpAccept=text/xml

14 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

https://api.elsevier.com/content/article/PII:S0924857910003390?httpAccept=text/plain

14 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

International Journal of Antimicrobial Agents

14 July 2024

published in

1 reference

23 August 2017

volume

36

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

459-461

1 reference

Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs

14 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

14 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin

14 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin

14 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.

14 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

14 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.IJANTIMICAG.2010.07.011

14 July 2024

Identifiers

1 reference

23 August 2017

1 reference